Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Pages (from-to)38-40
JournalMultiple Sclerosis and Related Disorders
Volume34
DOIs
Publication statusPublished - 2019

Cite this